Does OSIMERTINIB Cause Transient ischaemic attack? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Transient ischaemic attack have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.1% of all adverse event reports for OSIMERTINIB.
27
Reports of Transient ischaemic attack with OSIMERTINIB
0.1%
of all OSIMERTINIB reports
0
Deaths
12
Hospitalizations
How Dangerous Is Transient ischaemic attack From OSIMERTINIB?
Of the 27 reports, 12 (44.4%) required hospitalization.
Is Transient ischaemic attack Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Transient ischaemic attack?
APIXABAN (1,157)
RIVAROXABAN (820)
LENALIDOMIDE (655)
ADALIMUMAB (604)
ASPIRIN (587)
ROSIGLITAZONE (585)
NAPROXEN (521)
LEVOTHYROXINE (517)
DABIGATRAN ETEXILATE (471)
CLOPIDOGREL BISULFATE (454)
Which OSIMERTINIB Alternatives Have Lower Transient ischaemic attack Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN